Dr T L Dormandy
(Department of Chemical Pathology, Whittington Hospital (Archway Wing), London N19) Vitamin E and Antoxidant Activity Autoxidation and Antioxidants Within the last thirty years vitamin E has been hailed as an elixir of youth and dismissed as a tonic for tired sheep. Between these extremes almost every shade of opinion has been expressed. One reason for such disagreement is the ignorance which still surrounds biological autoxidation and the mechanisms which protect against it. Autoxidation (or peroxidation, as it is increasingly called) means the nonenzymic interaction between unsaturated compounds, mainly polyunsaturated lipids and molecular oxygen. Orthodox biochemistry is so firmly rooted in enzymology that, until comparatively recently, such nonenzymic processes were tacitly but resolutely ignored. Yet polyunsaturated lipids are essential constituents of all cells; and, in the presence of oxygen and ubiquitous trace catalysts, they are intrinsically autoxidizable. Their actual autoxidation depends on the random generation of highly reactive free radicals derived from the reduction of the oxygen molecule, 02, Conditioned as we are to the continuous and predictable working of enzymic systems, the randomness of this event (comparable in some respects to the randomness of genetic mutations) remains an intellectual barrier as well as a technical difficulty. In the darkness and the cold of a refrigerator a lump of butter will remain 'fresh' for a long time; but even there, sooner or later, it will develop signs of rancidity. Rancidity means autoxidation, not so much the primary formation of lipid peroxides but their secondary breakdown into many, still imperfectly characterized, fragmentation products. In contrast to the generation of the initial free radicals this fragmentation is highly exergonic, virtually spontaneous and irreversible. In a biological system it is also wasteful and destructive, since there is no known mechanism whereby the energy set free can be used for biological work. If biologicali.e. enzymicoxidation sustains living cells like a finely tuned internal combustion engine, autoxidation is like dropping a lighted match into the petrol tank.
In contrast to the lump of butter in the refrigerator, we spend a lifetime exposed to light and other forms of high-energy irradiation, incubating ourselves at 37°C and more or less in perpetual, if not always productive, motion. Since we do not on any massive scale go rancid until a few hours after death we must assume that we are actively preserved, that every cell in our bodies is shielded by an extremely efficient antioxidant mechanism or several antioxidant mechanisms (Barber & Bernheim 1967 , Dormandy 1969 . It is in this context that the role and importance of vitamin E must be assessed.
Vitamin E in Vitro and in Animals
There is no doubt whatever that when vitamin E is added to highly autoxidizable mixtures in vitrowhether the mixture is a simple lipid emulsion or homogenized tissueit behaves as an efficient antioxidant or preservative. In this respect it is not, of course, unique among biological compounds: under varying conditions many phenolic substances, trace elements and enzymes act as autoxidation inhibitors. Nor are the tocopherols as powerful as some of the synthetic preservatives widely used in the chemical and food industry (Witting 1975) . But they are nontoxic and readily available. The question is: are they essential?
If there can be no doubt about the antioxidant potency of the tocopherols in vitro, it is only marginally less certain that vitamin E deficiency is the specific cause of well defined syndromes in animals. Between species the clinical manifestations differ, ranging from sterility in sheep and rats to encephalomalacias in chicks, muscular dystrophies in cows and demyelination in horses (Wolbach & Bessey 1942 , Pappenheimer 1943 , Olcott & Mattill 1941 . Strong experimental evidence suggests, moreover, that in all these syndromes the vitamin deficiency is associated with an increased susceptibility to autoxidation of the animal as a whole and in particular of the tissue or organ clinically affected. In short, the clinical manifestations and the biochemical abnormality are almost certainly causally linked. Even in animals, however, vitamin E is not the only anti-oxidant mechanism. The vitamin acts synergistically with the trace element selenium, which has been shown to be an essential component of the enzyme glutathione peroxidase; and in recent years a number of additional protective enzymes (notably the superoxide dismutases) have been identified. Other antioxidant mechanisms probably work not by scavenging potentially dangerous free radicals but by complexing, and in this way inhibiting, essential autoxidation catalysts such as iron. Nevertheless the critical fact is that when vitamin E is added to the diet the clinical symptoms and signs disappear, and so does the abnormal tendency of the animals and the diseased organs to autoxidize. Unfortunately, the evidence is more tenuous in man.
Vitamin E in Man
From the point of view of human medicine the most tantalizing fact about vitamin E is that many of the animal diseases which are associated with tocopherol deficiency (and which respond to it) appear to have close human counterparts (Anderson 1973). The encephalomalacias, the skeletal myopathies, and the various demyelinating processes in particular spring to mind. So far none of these human counterparts has either been shown to be caused by vitamin E deficiency or to be rapidly improved by vitamin E therapy. Of course the question can be turned upside down, and one may reasonably ask: has vitamin E deficiency as the underlying cause been conclusively disproved? The only conclusive disproof would be if some alternative cause were discovered or if some other form of treatment proved successful. By these criteria the question must remain open. It must also be said that many of the trials leading to negative conclusions have been as slipshod as the reports claiming extravagant success.
What is true ofindividual diseases also applies to that most complex of degenerative syndromes, ageing. Vitamin E and several other antioxidants can significantly prolong the life span of miceat least of mice held in captivitybut similar claims made for man have never been adequately tested. Man living in an industrially advanced society consumes many million times more preservativesi.e. antioxidantsthan man living close to nature, and, despite the hazards of an industrial society, he lives longer. This is the sum total of the evidence if one cares to dignify it by that name.
To the statement that vitamin E deficiency has not been shown to be the cause of human disease, one exception must be made. A few weeks after birth some premature babies develop severe himolytic anxmia, thrombocytopenia and generalized oedema. The condition responds promptly to vitamin E, and circumstantial but strong evidence suggests that it is caused by vitamin deficiency (Hassan et al. 1966 , Oski & Barness 1967 . There is no comparable syndrome in adults. In steatorrhoea from whatever cause there is often some degree of vitamin E deficiency; and a low serum vitamin E is also characteristic of the rare condition ofacanthocytosis or abetalipoproteinmmia (Dodge et al. 1967 ). Yet no clearly recognizable clinical features can be ascribed in either condition to vitamin E lack. In normal human serum, moreover, vitamin E contributes only marginally to antioxidant activity when this activity is measured in a biological assay system (Stocks et al. 1974) . Perhaps in the human species the role of the vitamin consists of a brief star turn during late intrauterine life.
In assessing the possible relevance of vitamin E to human medicine one final question must be asked. Even if diseases are not caused by vitamin E deficiency, might the vitamin still be beneficial when given as a drug? The answer depends on how critical (as distinct from essential) antioxidant protection is in man. It is only in the last few years that the possibility has been seriously envisaged; but, allowing for the technical difficulties of demonstrating, let alone measuring, autoxidation in cells and tissues, more and more evidence points to autoxidative (or peroxidative) damage as an important event in a variety of pathological processes. In some degenerative diseases it could be the basic biochemical fault. In others where the basic fault is known to be different it could still be the immediate cause of cell malfunction or death.
In many hvmolytic syndromes, for example, red blood cells are abnormally susceptible to lipid autoxidation; and the autoxidation of membrane lipids (whatever the underlying biochemical defect) could be the immediate cause of cell lysis (Dormandy 1971 , Winterbourne & Carrell 1974 , Rachmilewitz 1974 . If this were so and if such cells could be afforded extra antioxidant protection, the effect might be comparable to splenectomy, mitigating the illness without necessarily affecting the underlying lesion (Rachmilewitz 1975) .
Summary
Forty years after its discovery, vitamin E remains a biochemical Don Basilio, not to be trusted or believed but impossible to dismiss. It is a powerful antioxidant in vitro, in many animals and probably in the newborn. To assess its physiological role and possible therapeutic usefulness in the human adult we need to know more about the mechanisms which normally protect from autoxidative damage. The K group of vitamins comprises two major chemical forms, both fat-soluble and widely distributed in nature: (1) Vitamin K1, now known as phylloquinone, which is produced exclusively by plants.
(2) Vitamin K2, of which there is a series of compounds termed collectively the menaquinones, and produced only by microorganisms (Pennock 1966) .
Both forms of the vitamin consist of a naphthoquinone ring with a methyl group in the 2 position of the ring, and a side-chain attached to the ring in the 3 position. Vitamin K1 has a phytyl side-chain made up of four isoprene units linked together (Fig 1) . The side-chain in the K2 vitamins is of variable length and gives rise to a number of compounds known as the MK series, the number of isoprene units in the side-chain varying from 1-13 although only 4-13 are found in nature (Fig 1) . Also shown in Fig 1 is menadione, a synthetic compound with relatively little biological activity.
The only established function of vitamin K , and menaquinones in man and other mammals is in the synthesis by the liver of four plasma coagulation factors, i.e. factor II (prothrombin) and factors VII, IX and X. The K vitamins bring about the carboxylation of the glutamic acid residues at the NH2-terminal end of the polypeptide chains of these clotting factors, which thereby acquire the property of binding calcium ions and thus become biologically active in the coagulation mechanism (Stenflo 1974); but the biochemical mechanism by which the K vitamins bring about these molecular changes is unknown.
Our studies have been concerned with the metabolism of tritium-labelled vitamin K1, and in this paper we review our findings and consider some of the outstanding problems. Absorption ofan Oral Dose of Vitamin K Oral doses of 1 mg vitamin K were detected in the plasma 30 min after ingestion, the levels then rising sharply to reach a peak at 2-4 hours (Shearer et al. 1970) . These observations suggest that vitamin K1 is absorbed mainly in the upper part of the small bowel. It is likely that vitamin K1 is absorbed largely unchanged from the gut, since chromatographic analysis of plasma at the time of peak absorption showed that over 800% of the radioactivity was present as vitamin K, and associated mainly with large molecular size material, probably chylomicrons and low density lipoproteins.
The absorbed vitamin K, was cleared from the plasma relatively fast initially and then more slowly, the plasma level at 24 hr having fallen to 10-20 % of the peak level (Shearer et al. 1970 ).
Since the liver is the site of synthesis of the vitamin K dependent coagulation factor it is likely that most of the absorbed vitamin K is removed from the plasma by the hepatic cells, but the precise tissue distribution in man is not known. The route of absorption of vitamin K1 from the gut to the blood appears to be via the intestinal lymphatics (Blomstrand & Forsgren 1968) . A small amount of water-soluble radioactive material was found in the plasma, reaching a peak
